# Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy

> **NCT07707648** · EARLY_PHASE1 · RECRUITING · sponsor: **Beaura for Para Pharmaceutical Products Trading LLC** · enrollment: 74 (estimated)

## Conditions studied

- Fatigue Related to Cancer Treatment

## Interventions

- **DRUG:** encer
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07707648
- **Lead sponsor:** Beaura for Para Pharmaceutical Products Trading LLC
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07707648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07707648, "Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07707648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*